Results 141 to 150 of about 8,639 (159)

Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials

Respiratory Medicine, 2017
Robert Tosiello, Edward M Kerwin, James F Donohue   +2 more
exaly  

Glycopyrrolate in children

Anaesthesia, 1980
J N Lunn
exaly  

Glycopyrrolate methobromide

Canadian Anaesthetists' Society Journal, 1974
Gordon Michael Wyant, G M Wyant
exaly  

Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways

British Journal of Pharmacology, 1999
Magdi Yacoub, Peter J. Barnes, Maria G Belvisi   +2 more
exaly  

Effects of intravenous administration of glycopyrrolate and atropine in anaesthetised patients

Anaesthesia, 1981
R K Mirakhur
exaly  

Pharmacology, toxicology and clinical safety of glycopyrrolate

Toxicology and Applied Pharmacology, 2019
Ana Kilic, Clarissa Masur, Christoph Abels   +2 more
exaly  

Preliminary study of glycopyrrolate in the management of drooling

Journal of Paediatrics and Child Health, 1997
L M Stern
exaly  

Effects of glycopyrrolate and atropine on heart rate variability

Acta Anaesthesiologica Scandinavica, 1991
Timo Kaila, K Antila, T Ali-Melkkilä
exaly  

Oral Glycopyrrolate Alleviates Drooling in a Patient with Tongue Cancer

Journal of Pain and Symptom Management, 1999
P Sjøgren
exaly  

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways

British Journal of Pharmacology, 2006
Pierangelo Geppetti, Riccardo Patacchini, Selena Harrison   +2 more
exaly